{"title":"肝细胞癌放射治疗的证据越来越多，是否增加了老年患者放射治疗的使用？","authors":"Tae Hyun Kim","doi":"10.3857/roj.2023.00710","DOIUrl":null,"url":null,"abstract":"Primary liver cancer, mostly hepatocellular carcinoma (HCC), is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide [1]. HCC develops mostly in patients with chronic liver disease, such as cirrhosis from hepatitis B and C virus infection, alcoholic abuse","PeriodicalId":94184,"journal":{"name":"Radiation oncology journal","volume":"41 3","pages":"141-143"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/9f/roj-2023-00710.PMC10556838.pdf","citationCount":"0","resultStr":"{\"title\":\"Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?\",\"authors\":\"Tae Hyun Kim\",\"doi\":\"10.3857/roj.2023.00710\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Primary liver cancer, mostly hepatocellular carcinoma (HCC), is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide [1]. HCC develops mostly in patients with chronic liver disease, such as cirrhosis from hepatitis B and C virus infection, alcoholic abuse\",\"PeriodicalId\":94184,\"journal\":{\"name\":\"Radiation oncology journal\",\"volume\":\"41 3\",\"pages\":\"141-143\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/9f/roj-2023-00710.PMC10556838.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiation oncology journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3857/roj.2023.00710\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation oncology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3857/roj.2023.00710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
Primary liver cancer, mostly hepatocellular carcinoma (HCC), is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide [1]. HCC develops mostly in patients with chronic liver disease, such as cirrhosis from hepatitis B and C virus infection, alcoholic abuse
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
